A.Menarini Pharma U.K. S.R.L.

Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, Buckinghamshire, HP10 0HH
Telephone: +44 (0) 1628 856400
Fax: +44 (0) 1628 856402
Medical Information Direct Line: 0800 085 8678
Medical Information e-mail: menarini@medinformation.co.uk
Out of Hours contact: menarini@medinformation.co.uk

Patient Information Leaflet last updated on the eMC: 12/02/2010
PIL Migard

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 04/11/2008 and displayed until 12/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 05/06/2008 and displayed until 04/11/2008
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 11/03/2008 and displayed until 05/06/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change due to harmonisation of patient information leaflet
Updated on 20/03/2007 and displayed until 11/03/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 21/03/2006 and displayed until 20/03/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 07/03/2006 and displayed until 21/03/2006
Reasons for adding or updating:
  • Company name change or merger
Updated on 28/09/2004 and displayed until 07/03/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   frovatriptan succinate monohydrate